"A major publisher of scholarly medical and science articles has retracted 43 papers because of “fabricated” peer reviews amid signs of a broader fake peer review racket affecting many more publications. The publisher is BioMed Central, based in the United Kingdom, which puts out 277 peer-reviewed journals. A partial list of the retracted articles suggests most of them were written by scholars at universities in China, including China Medical University, Sichuan University, Shandong University and Jiaotong University Medical School. But Jigisha Patel, associate editorial director for research integrity at BioMed Central, said it’s not “a China problem. We get a lot of robust research of China. We see this as a broader problem of how scientists are judged.” Meanwhile, the Committee on Publication Ethics, a multidisciplinary group that includes more than 9,000 journal editors, issued a statement suggesting a much broader potential problem. The committee, it said, “has become aware of systematic, inappropriate attempts to manipulate the peer review processes of several journals across different publishers.” Those journals are now reviewing manuscripts to determine how many may need to be retracted, it said."
Issues and developments related to ethics, information, and technologies, examined in the ethics and intellectual property graduate courses I teach at the University of Pittsburgh School of Computing and Information. My Bloomsbury book "Ethics, Information, and Technology" will be published in Summer 2025. Kip Currier, PhD, JD
Showing posts with label BioMed Central. Show all posts
Showing posts with label BioMed Central. Show all posts
Saturday, March 28, 2015
Major publisher retracts 43 scientific papers amid wider fake peer-review scandal; Washington Post, 3/28/15
Fred Barbash, Washington Post; Major publisher retracts 43 scientific papers amid wider fake peer-review scandal:
Subscribe to:
Posts (Atom)